sur EUROBIO-SCIENTIFIC (EPA:ALERS)
EB Development Surpasses 90% Stake in Eurobio Scientific
Paris, May 19, 2024 – Eurobio Scientific, a prominent French company in in vitro medical diagnostics and life sciences, announced that EB Development has acquired over 90% of its share capital. This significant milestone follows EB Development's purchase of Eurobio Scientific shares in the market, raising its ownership to an exact 90.01% shareholding and equivalent voting rights.
Eurobio Scientific is known for its contributions to specialty in vitro diagnostics, covering areas such as transplantation, immunology, and infectious diseases. The company boasts a strong international presence with production units and subsidiaries across Europe and the USA.
The next major financial event for Eurobio Scientific is its Annual General Meeting, scheduled for June 19, 2025.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de EUROBIO-SCIENTIFIC